20/20 Biolabs

20/20 Biolabs, Inc. was incorporated in Delaware on August 7, 2000. The company develops and commercializes AI-driven, lab-based blood tests focused on the early detection and prevention of cancer and chronic diseases. Under the OneTest brand, the company offers two primary families of laboratory tests: OneTest for Cancer, a multi-cancer early detection blood test, and OneTest for Longevity, which is expected to launch in the first half of 2026. Both tests are conducted at the company’s CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland, which also features a clinical laboratory innovation accelerator specifically designed for diagnostic startups.